Impact of intracellular alpha fetoprotein on retinoic acid receptors-mediated expression of GADD153 in human hepatoma cell lines

International Journal of Cancer

Volumn 130, Issue 4, 2012, Pages 754-764

  Li, Chaoying ^a   Wang, Shanshan ^a   Jiang, Wei ^a   Li, Hui ^a   Liu, Zhongmin ^a   Zhang, Chao ^a   McNutt, Michael A ^a   Li, Gang ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

all trans retinoic acid; alpha fetoprotein; growth arrest and DNA damage inducible gene 153; hepatocellular carcinoma; retinoic acid receptor

Indexed keywords

4 [2 [5,6 DIHYDRO 5,5 DIMETHYL 8 (4 METHYLPHENYL) 2 NAPHTHYL]ETHYNYL]BENZOIC ACID; ALPHA FETOPROTEIN; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; RETINOIC ACID; RETINOIC ACID RECEPTOR; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; CELL NUCLEUS; CELL STRAIN HEPG2; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; DOWN REGULATION; GADD153 GENE; GENE; GENE EXPRESSION PROFILING; GENETIC TRANSFECTION; HEPATOMA CELL; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROTEIN DNA BINDING; UPREGULATION;

ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; DNA; GENE EXPRESSION PROFILING; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; RECEPTORS, RETINOIC ACID; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR CHOP; TRETINOIN;

EID: 83955161219     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.26025     Document Type: Article

References (36)

1. Mizejewski GJ,. Biological role of alpha-fetoprotein in cancer: prospects for anticancer therapy. Expert Rev Anticancer Ther 2002; 2: 709-35. (Pubitemid 35469493)
2. Mizejewski GJ, MacColl R,. Alpha-fetoprotein growth inhibitory peptides: Potential leads for cancer therapeutics. Mol Cancer Ther 2003; 2: 1243-55.
3. Mizejewski GJ, Butterstein G,. Survey of functional activities of alpha-fetoprotein derived growth inhibitory peptides: review and prospects. Curr Protein Pept Sci 2006; 7: 73-100.
4. Mizejewski GJ,. Alpha-fetoprotein (AFP)-derived peptides as epitopes for hepatoma immunotherapy: a commentary. Cancer Immunol Immunother 2009; 58: 159-70.
5. Muehlemann M, Miller KD, Dauphinee M, Mizejewski GJ,. Review of growth inhibitory peptide as a biotherapeutic agent for tumor growth, adhesion, and metastasis. Cancer Metastasis Rev 2005; 24: 441-67. (Pubitemid 41569983)
6. Mizejewski GJ,. Therapeutic use of human alpha-fetoprotein in clinical patients: is a cancer risk involved? Int J Cancer 2011; 128: 239-242.
7. Vakharia D, Mizejewski GJ,. Human alpha-fetoprotein peptides bind estrogen receptor and estradiol, and suppress breast cancer. Breast Cancer Res Treatment 2000; 63: 41-52.
8. Li MS, Liu XH, Zhou S, Li PF, Li G,. Effects of alpha fetoprotein on escape of Bel 7402 cells from attack of lymphocytes. BMC Cancer 2005; 5: 96.
9. Li MS, Zhou S, Liu XH, Li PF, McNutt MA, Li G,. alpha-Fetoprotein shields hepatocellular carcinoma cells from apoptosis induced by tumor necrosis factor-related apoptosis-inducing ligand. Cancer Lett 2007; 249: 227-34. (Pubitemid 46452932)
10. Tong MJ, Hsien C, Song JJ, Kao JH, Sun HE, Hsu L, Han SH, Durazo FA, Saab S, Blatt LM,. Factors Associated with progression to hepatocellular carcinoma and to death from liver complications in patients with HBsAg-positive cirrhosis. Dig Dis Sci 2009; 54: 1337-46.
11. Chan SL, Mo FKF, Johnson PJ, Hui EP, Ma BBY, Ho WM, Lam KC, Chan ATC, Mok TSK, Yeo W,. New utility of an old marker: serial alpha-fetoprotein measurement in predicting radiologic response and survival of patients with hepatocellular carcinoma undergoing systemic chemotherapy. J Clin Oncol 2009; 27: 446-52.
12. Park UJ, Kim YH, Kang KJ, Lim TJ,. Risk factors for early recurrence after surgical resection for hepatocellular carcinoma. Korean J Hepatol 2008; 14: 371-80.
13. Dauphinee MJ, Mizejewski GJ,. Human alpha-fetoprotein contains potential heterodimerization motifs capable of interaction with nuclear receptors and transcript ion/growth factors. Med Hypotheses 2002; 58: 453-61.
14. Li M, Li H, Li C, Guo L, Liu H, Zhou S, Liu X, Chen Z, Shi S, Wei J, McNutt MA, Li G,. Cytoplasmic alpha-fetoprotein functions as a co-repressor in RA-RAR signaling to promote the growth of human hepatoma Bel 7402 cells. Cancer Lett 2009; 285: 190-9.
15. Li M, Li H, Li C, Zhou S, Guo L, Liu H, Wei J, Liu X, Li P, McNutt MA, Li G,. Alpha fetoprotein is a novel protein-binding partner for caspase-3 and blocks the apoptotic signaling pathway in human hepatoma cells. Int J Cancer 2009; 124: 2845-54.
16. Li M, Li, Hui, Li C, Wang S, Jiang W, Liu Z, Zhou S, Liu X, McNutt MA, Li G,. Alpha-fetoprotein, a new member of intracellular signal molecules in regulation of the PI3K/AKT signaling in human hepatoma cell lines. Int J Cancer 2011; 128: 524-532.
17. Nakanishi M, Tomaru Y, Miura H, Hayashizaki Y, Suzuki M,. Identification of transcriptional regulatory cascades in retinoic acid-induced growth arrest of HepG2 cells. Nucleic Acids Res 2008; 36: 3443-54. (Pubitemid 351859011)
18. Lovat PE, Oliverio S, Ranalli M, Corazzari M, Rodolfo C, Bernassola F, Aughton K, Maccarrone M, Hewson QDC, Pearson ADJ, Melino G, Piacentini M, et al. GADD153 and 12-lipoxygenase mediate fenretinide-induced apoptosis of neuroblastoma. Cancer Res 2002; 62: 5158-67. (Pubitemid 35024586)
19. Ron D, Habener JF,. Chop, a novel developmentally regulated nuclear-protein that dimerizes with transcription factors c/ebp and lap and functions as a dominant-negative inhibitor of gene-transcription. Genes Dev 1992; 6: 439-53.
20. Kim S-H, Hwang C-I, Juhnn Y-S, Lee J-H, Park W-Y, Song Y-S,. GADD153 mediates celecoxib-induced apoptosis in cervical cancer cells. Carcinogenesis 2007; 28: 223-31. (Pubitemid 44942647)
21. Okada T, Yoshida H, Akazawa R, Negishi M, Mori K,. Distinct roles of activating transcription factor 6 (ATF6) and double-stranded RNA-activated protein kinase-like endoplasmic reticulum kinase (PERK) in transcription during the mammalian unfolded protein response. Biochem J 2002; 366: 585-94. (Pubitemid 35001703)
22. Li H, Liu H, Wang Z, Liu X, Guo L, Huang L, Gao L, McNutt MA, Li G,. The role of transcription factors Sp1 and YY1 in proximal promoter region in initiation of transcription of the mu opioid receptor gene in human lymphocytes. J Cell Biochem 2008; 104: 237-50.
23. Liu H, Li H, Guo LY, Li CY, Li MS, Jiang W, Liu XH, McNutt MA, Li G,. The mechanism involved in the repression of the mu opioid receptor gene expression in CEM x 174 cells infected by simian immunodeficiency virus. J Leukocyte Biol 2009; 85: 684-91.
24. Visalli RJ, Knepper J, Goshorn B, Vanover K, Burnside DM, Irven K, McGauley R, Visalli M,. Characterization of the varicella-zoster virus ORF25 gene product: pORF25 interacts with multiple DNA encapsidation proteins. Virus Res 2009; 144: 58-64.
25. Li M, Li H, Li C, Guo L, Liu H, Zhou S, Liu X, Chen Z, Shi S, Wei J, McNutt MA, Li G,. Cytoplasmic alpha-fetoprotein functions as a co-repressor in RA-RAR signaling to promote the growth of human hepatoma Bel 7402 cells. Cancer Lett 2009; 285: 190-199.
26. Liu H, Li H, Guo LY, Li MS, Li CY, Wang SS, Jiang W, Liu XH, McNutt MA, Li G,. Mechanisms involved in phosphatidylinositol 3-kinase pathway mediated up-regulation of the mu opioid receptor in lymphocytes. Biochem Pharmacol 2010; 79: 516-23.
27. Jousse C, Bruhat A, Carraro V, Urano F, Ferrara M, Ron D, Fafournoux P,. Inhibition of CHOP translation by a peptide encoded by an open reading frame localized in the chop 5 ′ UTR. Nucleic Acids Res 2001; 29: 4341-51. (Pubitemid 33064774)
28. Oyadomari S, Mori M,. Roles of CHOP/GADD153 in endoplasmic reticulum stress. Cell Death Differ 2004; 11: 381-9. (Pubitemid 38489416)
29. Avellini C, Orsaria M, Baccarani U, Adani GL, Lorenzin D, Bresadola V, Bresadola F, Beltrami CA,. Apurinic apyrimidinic endonuclease/redox effector factor 1 immunoreactivity and grading in hepatocellular carcinoma risk of relapse after liver transplantation. Transplant Proc 2010; 42: 1204-8.
30. Marrero JA, Feng ZD, Wang YH, Nguyen MH, Befeler AS, Roberts LR, Reddy KR, Harnois D, Llovet JM, Normolle D, Dalhgren J, Chia D, et al. Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma. Gastroenterology 2009; 137: 110-8.
31. Gao J-D, Shao Y-F, Xu Y, Ming L-H, Wu Z-Y, Liu G-T, Wang X-H, Gao W-H, Sun Y-T, Feng X-L, Liang L-M, Zhang Y-H, et al. Tight association of hepatocellular carcinoma with HBV infection in North China. Hepatobiliary Pancreat Dis Int 2005; 4: 46-9. (Pubitemid 40347512)
32. Mizejewski G,. Hypothesis: an apparent dimerization motif in the third domain of alphafetoprotein: molecular mimicry of the steroid/thyroid nuclear receptor superfamily. Bioessays 1993; 15: 427-32.
33. Freemantle SJ, Spinella MJ, Dmitrovsky E,. Retinoids in cancer therapy and chemoprevention: promise meets resistance. Oncogene 2003; 22: 7305-15. (Pubitemid 37487162)
34. Wang LH, Levin MS,. Suppression of FGF signaling: a putative mechanism for the chemopreventive effects of acyclic retinoid in hepatocellular carcinoma. Gastroenterology 2005; 128: 228-31. (Pubitemid 40039974)
35. Clerici C, Castellani D, Russo G, Fiorucci S, Sabatino G, Giuliano V, Gentili G, Morelli O, Raffo P, Baldoni M, Morelli A, Toma S,. Treatment with all-trans retinoic acid plus tamoxifen and vitamin E in advanced hepatocellular carcinoma. Anticancer Res 2004; 24: 1255-60. (Pubitemid 38624971)
36. Heim KC, White KA, Deng D, Tomlinson CR, Moore JH, Freemantle SJ, Spinella MJ,. Selective repression of retinoic acid target genes by RIP140 during induced tumor cell differentiation of pluripotent human embryonal carcinoma cells. Mol Cancer 2007; 6.